POPPY: Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse
Study Details
Study Description
Brief Summary
The aim of this study is to determine the effectiveness and cost-effectiveness of pelvic floor muscle training in the management of pelvic organ prolapse in women.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Pelvic organ prolapse is a common problem that adversely affects the daily activities and quality of life of many women. Pelvic floor muscle training interventions are commonly used by physiotherapists to manage prolapse. However, a Cochrane review found limited evidence to support the effectiveness of such interventions. Based on the findings of a successful feasibility study, this multi-centre randomised controlled trial will address the paucity of evidence. 556 symptomatic women with diagnosed prolapse will be enrolled in 16 UK centres and 1 New Zealand centre over 16 months and randomised to pelvic floor muscle training plus lifestyle advice, or to receive a lifestyle leaflet only. Principal measures of outcome are: prolapse symptoms, prolapse severity, and subsequent further treatment up to 12 months after trial entry.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: 1 It consists of five outpatient appointments (weeks 0, 2, 6, 11 and 16) with a local trial physiotherapist at a trial centre. At the first appointment a standardised history is taken from the woman, anatomy and function of the pelvic floor muscles are taught, and types of prolapse described, using diagrams and a model pelvis. Women are taught how to contract the muscles, and also how to contract and hold prior to an event that increases intra-abdominal pressure ("the Knack"). Pelvic floor muscles are assessed by vaginal examination and recorded on a dedicated form at each appointment thus determining the content of a single set of exercises for each woman. At least three sets of exercises daily is recommended. Women use an exercise diary to record compliance. Tailored advice is given on ways of reducing intra-abdominal pressure, e.g. advice on weight loss, chronic cough, heavy lifting and general exercise. |
Procedure: Pelvic Floor Muscle Training
Women in the intervention group attend 5 physiotherapy sessions. At each appointment a clinical history is taken, pelvic floor muscle assessment carried out, exercises taught and prescribed, and appropriate lifestyle advice given. At the first of these appointments a detailed explanation of the pelvic anatomy and different types of prolapse is given.
|
No Intervention: 2 Women allocated to the control group will be sent a lifestyle advice leaflet only, and will have no planned contact with the centre until their consultant review appointment at six months. The leaflet gives instructions on seeking advice where appropriate about weight loss, constipation, and avoidance of heavy lifting, coughing and high impact exercise, with a view to minimising increases in intra-abdominal pressure which may cause prolapse to worsen. |
Outcome Measures
Primary Outcome Measures
- Prolapse symptom score (questions developed in feasibility study and undergoing validation). Primary economic outcome measures are: use of health services, average number of days of prolapse symptoms and further prolapse treatment needed/received [1 year]
Secondary Outcome Measures
- Prolapse-related quality of life, prolapse severity, need for further prolapse treatment. Other outcomes include: lifestyle changes, urinary symptoms, bowel symptoms, sexual symptoms, general health status. [1 year]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
New attendee at outpatient gynaecology clinic
-
Any type of prolapse
Exclusion Criteria:
-
Stage 0 or IV prolapse
-
Women reporting no symptoms of prolapse
-
Previous treatment for prolapse (surgery or formal instruction in Pelvic Floor Muscle Training [PMFT,]unless completed more than 5 years ago, pessary, unless pessary removed more than 12 months ago)
-
Unable to comply with PFMT
-
women who have urogenital atrophy requiring treatment with local oestrogens (after an 8 week course of local oestrogen such women can be included);
-
Pregnant or less than 6 months post-natal
-
Unable to give informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | St George Hospital | Sydney | Australia | ||
2 | Antrim Area Hospital | Antrim | Ireland | ||
3 | Belfast City Hospital | Belfast | Ireland | BT9 7AB | |
4 | Dunedin School of Medicine | Dunedin | New Zealand | P O Box 913 | |
5 | Crosshouse Hospital / Ayrshire Maternity Hospital | Kilmarnock | Ayrshire | United Kingdom | KA2 0BE |
6 | Forth Park Hospital | Kirkcaldy | Fife | United Kingdom | KY2 5RA |
7 | Aberdeen Royal Infirmary | Aberdeen | Grampian | United Kingdom | AB25 2ZN |
8 | North Hampshire Hospitals NHS Trust | Basingstoke | Hampshire | United Kingdom | RG24 9NA |
9 | Royal Infirmary of Edinburgh | Edinburgh | Lothian | United Kingdom | EH16 4SA |
10 | St John's Hospital | Livingston | West Lothian | United Kingdom | EH54 6PP |
11 | Birmingham Women's Hospital | Birmingham | United Kingdom | B15 2TG | |
12 | Bradford Royal Infirmary | Bradford | United Kingdom | BD9 6RJ | |
13 | Addenbrooke's Hospital | Cambridge | United Kingdom | CB2 8AF | |
14 | Chester Hospital | Chester | United Kingdom | CH2 1UL | |
15 | St Richard's Hospital | Chichester | United Kingdom | ||
16 | Ninewells Hospital | Dundee | United Kingdom | DD1 9SY | |
17 | Falkirk and District Royal Infirmary | Falkirk | United Kingdom | FK1 5QE | |
18 | Western Infirmary | Glasgow | United Kingdom | G11 6NT | |
19 | Glasgow Royal Infirmary | Glasgow | United Kingdom | G4 0SF | |
20 | Victoria Infirmary | Glasgow | United Kingdom | G42 9TY | |
21 | Southern General Hospital | Glasgow | United Kingdom | G51 4TF | |
22 | Castle Hill Hospital | Hull | United Kingdom | ||
23 | St James's University Hospital | Leeds | United Kingdom | ||
24 | St Mary's Hospital | Manchester | United Kingdom | M13 OJH | |
25 | Borders General Hospital | Melrose | United Kingdom | TD6 9BS | |
26 | James Cook University Hospital | Middlesbrough | United Kingdom | ||
27 | Worcestershire Royal Hospital | Worcester | United Kingdom | WR5 1DD | |
28 | York Hospital | York | United Kingdom |
Sponsors and Collaborators
- Glasgow Caledonian University
- Chief Scientist Office of the Scottish Government
- South Glasgow University Hospitals NHS Trust
- University of Aberdeen
- University of Otago
Investigators
- Principal Investigator: Suzanne Hagen, NMAHP Research Unit, Glasgow Caledonian University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CZH/4/377
- ISRCTN35911035